Cargando…

Vascular connexins have differing responses to tumor necrosis factor

Detalles Bibliográficos
Autor principal:	Ouellette, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083945/ http://dx.doi.org/10.1186/cc7223

Ejemplares similares

Tumor necrosis factor increases the sensitivity of the contractile apparatus in isolated mouse resistance arteries via a calcium-dependent mechanism
por: Ouellette, Y
Publicado: (2005)

Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy
por: Russo, R, et al.
Publicado: (2011)

Tumor necrosis factor alpha modulates fibroblast-like synoviocyte expression of lymphangiogenesis-associated vascular endothelial growth factor C
por: Connor, AM, et al.
Publicado: (2004)

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
por: Redlich, K, et al.
Publicado: (2003)

Interaction between etomidate and beta tumoral necrosis factor on hemodynamic response after cardiac surgery
por: Iribarren, JL, et al.
Publicado: (2015)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
por: Bayraktar, S, et al.
Publicado: (2008)

Serum tumor necrosis factor alpha increased during remission with Etanercept
por: Spirchez, Mihaela, et al.
Publicado: (2011)

Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
por: Kunisch, E, et al.
Publicado: (2005)

Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
por: Baraliakos, X, et al.
Publicado: (2005)

Risk factors for latent tuberculosis infection in RA patients treated with anti-tumor necrosis factor
por: Huang, Shiang-Fen, et al.
Publicado: (2012)

Regulation of myeloid cell function and MHC class II expression by tumor necrosis factor
por: Mueller, RB, et al.
Publicado: (2005)

Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment
por: Modesto, C, et al.
Publicado: (2011)

Different molecules at the surface of stimulated T cells induce IL-1α, tumor necrosis factor and IL-1 receptor antagonist in human monocytes
por: Burger, D, et al.
Publicado: (2004)

Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

IL-1/tumor necrosis factor receptor gene expression characterizes sepsis in critically ill systemic inflammatory response syndrome patients
por: Lissauer, M, et al.
Publicado: (2007)

Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
por: Kostina, YO, et al.
Publicado: (2011)

Tumor necrosis factor alpha reverses the immunosuppressive properties of mesenchymal stem cells in collagen-induced arthritis
por: Djouad, F, et al.
Publicado: (2005)

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Tumor necrosis factor alpha downregulates bone morphogenetic protein expression and matrix macromolecule synthesis in articular cartilage
por: Bobacz, K, et al.
Publicado: (2004)

Evidence based recommendations for diagnosis and treatment of tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)
por: Haar, Nienke Ter, et al.
Publicado: (2014)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Laminin, but not lipopolysaccharide, IL-1 or tumor necrosis factor alpha, induces IL-16 gene activity in synovial fibroblasts
por: Aicher, W, et al.
Publicado: (2003)

Tumor necrosis factor alpha induced proliferation of adult neural stem cells is mediated via NF-κB
por: Widera, Darius, et al.
Publicado: (2007)

Immunohistochemical study of tumor necrosis factor-alpha(TNF- α) expression in lung, liver, and spleen during aspergillosis infection
por: Dheeb, Batol Imran
Publicado: (2014)

Methotrexate, through adenosine release, downregulates tumor necrosis factor alpha-induced synovial fibroblast IL-15 expression and proliferation
por: Miranda, E, et al.
Publicado: (2005)

T cell contact-mediated induction of tumor necrosis factor alpha in peripheral blood monocytes is inhibited by autologous serum in rheumatoid arthritis
por: Wagner, U, et al.
Publicado: (2003)

PReS-FINAL-2032: Changes in immunogenic profile in patients with juvenile idiopathic arthritis exposed to anti tumoral necrosis factor therapy
por: Guillen Astete, CA, et al.
Publicado: (2013)

Tumor necrosis factor polymorphisms in psoriatic arthritis: association with the promoter polymorphism TNF-857 independent of the PSORS1 risk allele
por: Reich, K, et al.
Publicado: (2007)

Moderate hypothermia during cardiopulmonary bypass reduces intramyocardial expression of tumor necrosis factor alpha via inhibition of AP-1
por: Ma, Q, et al.
Publicado: (2005)

Vasoplegic syndrome in cardiac surgery: role of synergism between polymorphism of tumor necrosis factor beta and plasminogen activator inhibitor type 1
por: Iribarren, JL, et al.
Publicado: (2015)

Connexin43 and AMPK Have Essential Role in Resistance to Oxidative Stress Induced Necrosis
por: Zhao, Chunshan, et al.
Publicado: (2017)

Different molecules at the surface of stimulated T cells induce IL-1beta, tumour necrosis factor and IL-1RA in human monocytes
por: Burger, D, et al.
Publicado: (2005)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
por: Dandekar, P, et al.
Publicado: (2015)

Newly diagnosed, treatment-naive patients with rheumatoid arthritis have early abnormalities of vascular and myocardial function
por: Erhayiem, Bara, et al.
Publicado: (2015)

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept
por: Baraliakos, X, et al.
Publicado: (2005)

Impact of periprocedural myocardial necrosis on short term clinical outcome
por: Hamdi, M, et al.
Publicado: (2015)

Patients with systemic lupus erythematosus have impaired strain and vascular function which is incremental to that caused by traditional risk factors: insights from Cardiovascular Magnetic Resonance
por: Ntusi, Ntobeko A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7fu8g8v2347h2039abnmaspn03